Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-012242
Filing Date
2022-02-23
Accepted
2022-02-23 16:37:11
Documents
2
Period of Report
2022-02-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1626
2 EX-24 DOCUMENT attachment1.htm EX-24 2225
  Complete submission text file 0001209191-22-012242.txt   5574
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Issuer) CIK: 0001069308 (see all company filings)

EIN.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 WASHINGTON STREET ONE GATEWAY CENTER, SUITE 351 NEWTON MA 02458
Business Address
Quartel Adrian W (Reporting) CIK: 0001910132 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33004 | Film No.: 22664415